Abstract: Described are injectable formulations of nanoparticulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise nanoparticulate olanzapine.
Type:
Grant
Filed:
November 16, 2005
Date of Patent:
March 22, 2011
Assignee:
Elan Pharma International Limited
Inventors:
Gary Liversidge, Scott Jenkins, Elaine Merisko Liversidge